These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 7010105

  • 1. [Leishmaniases: parasitic diseases of the immune system?].
    Shuĭkina EE.
    Med Parazitol (Mosk); 1980; 49(6):16-22. PubMed ID: 7010105
    [No Abstract] [Full Text] [Related]

  • 2. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ, Teixeira CR, Andrade BB, Barral-Netto M, Barral A.
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [Abstract] [Full Text] [Related]

  • 3. [Current problems of the study and prevention of leishmaniasis].
    Saf'ianova VM.
    Med Parazitol (Mosk); 1984 Jan; (2):45-51. PubMed ID: 6374406
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical immunological variants of leishmaniasis].
    Shuĭkina EE.
    Med Parazitol (Mosk); 1980 Jan; 49(3):75-81. PubMed ID: 6993910
    [No Abstract] [Full Text] [Related]

  • 5. Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii.
    Bryceson AD, Bray RS, Dumonde DC.
    Clin Exp Immunol; 1974 Feb; 16(2):189-202. PubMed ID: 4619877
    [Abstract] [Full Text] [Related]

  • 6. [Immunopathogenesis of Leishmania infections].
    Yurdakul P.
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [Abstract] [Full Text] [Related]

  • 7. Nature of resistance to leishmaniasis in experimental rodents.
    Gorczynski RM.
    Dev Comp Immunol; 1982 Jul; 6(2):199-207. PubMed ID: 6807726
    [No Abstract] [Full Text] [Related]

  • 8. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D, Alexander J.
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [Abstract] [Full Text] [Related]

  • 9. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ, Olivier M.
    Parasitology; 2005 Oct; 130 Suppl():S27-35. PubMed ID: 16281989
    [Abstract] [Full Text] [Related]

  • 10. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
    Murray HW, Masur H, Keithly JS.
    J Immunol; 1982 Jul; 129(1):344-50. PubMed ID: 7086136
    [No Abstract] [Full Text] [Related]

  • 11. Cytokines in the immunity and immunopathogenesis in leishmaniases.
    Saha B, Silvestre R.
    Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
    [Abstract] [Full Text] [Related]

  • 12. Vaccines in leishmaniasis: advances in the last five years.
    Brodskyn C, de Oliveira CI, Barral A, Barral-Netto M.
    Expert Rev Vaccines; 2003 Oct; 2(5):705-17. PubMed ID: 14711330
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of acquired immunity in leishmaniasis.
    Howard JG, Liew FY.
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov 13; 307(1131):87-98. PubMed ID: 6151691
    [Abstract] [Full Text] [Related]

  • 14. Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity.
    Gomes RB, Brodskyn C, de Oliveira CI, Costa J, Miranda JC, Caldas A, Valenzuela JG, Barral-Netto M, Barral A.
    J Infect Dis; 2002 Nov 15; 186(10):1530-4. PubMed ID: 12404176
    [Abstract] [Full Text] [Related]

  • 15. Virulence and disease in leishmaniasis: what is relevant for the patient?
    Rivas L, Moreno J, Cañavate C, Alvar J.
    Trends Parasitol; 2004 Jul 15; 20(7):297-301. PubMed ID: 15193556
    [No Abstract] [Full Text] [Related]

  • 16. Parasitic disease as a cause of immunosuppression.
    Nussenzweig RS.
    N Engl J Med; 1982 Feb 18; 306(7):423-4. PubMed ID: 6460186
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of Leishmania with the host macrophage.
    Handman E, Bullen DV.
    Trends Parasitol; 2002 Aug 18; 18(8):332-4. PubMed ID: 12377273
    [Abstract] [Full Text] [Related]

  • 18. Immunobiology of leishmaniasis.
    Sharma U, Singh S.
    Indian J Exp Biol; 2009 Jun 18; 47(6):412-23. PubMed ID: 19634705
    [Abstract] [Full Text] [Related]

  • 19. Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection.
    Bañuls AL, Bastien P, Pomares C, Arevalo J, Fisa R, Hide M.
    Clin Microbiol Infect; 2011 Oct 18; 17(10):1451-61. PubMed ID: 21933304
    [Abstract] [Full Text] [Related]

  • 20. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug 18; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.